Deal Ends Today·Save 35% annual plan
GLP-1 receptor agonistReviewed for 2026 plan year

Does Security Health Plan Cover Wegovy?

The verdict

Conditional on most plans

Security Health Plan's Wegovy coverage for weight loss is employer-dependent and not publicly published. The plan is affiliated with Marshfield Clinic, a large integrated health system in Wisconsin — but integrated delivery does not change the coverage gate: weight-loss Wegovy is covered only where the employer group purchased the anti-obesity benefit. This is a similar posture to sibling Wisconsin plans Network Health and Quartz, differentiated by the Marshfield-affiliated delivery model.

MedicareConditional
CommercialConditional
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Security Health Plan using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Security Health Plan drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Key facts

  • Security Health Plan is affiliated with Marshfield Clinic, a large integrated health system in Wisconsin — but Marshfield integration does not automatically include anti-obesity drug coverage; employer benefit design still decides.

    Security Health Plan plan materials

  • Wegovy's list price is $1,349/month; Novo Nordisk announced a reduction to approximately $675/month effective January 1, 2027.

    Novo Nordisk press release, 2026

  • The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries Wegovy weight-loss access at $50/month outside Part D — not counting toward the $2,100 OOP cap.

    CMS.gov, Medicare GLP-1 Weight Loss Drug Access Program

Plan types

Medicare vs. commercial coverage

Whether Security Health Plan covers Wegovy depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Conditional

Medicare Part D cannot cover Wegovy for weight loss by statute — this applies to all Security Health Plan Medicare plans. Security Health Plan Medicare plans can cover Wegovy for the cardiovascular risk-reduction indication (FDA-approved for adults with established CVD who are overweight or obese) with prior authorization. The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries weight-loss access to Wegovy at $50/month through December 31, 2027 — this operates outside Part D, so the $50 does not count toward the $2,100 OOP cap or TrOOP. Extra Help cannot be applied to Bridge copays. NovoCare savings card is not available to Medicare beneficiaries.

Commercial / Employer

Group & marketplace plans

Conditional

Security Health Plan commercial and employer plans cover Wegovy for weight loss only when the employer has purchased the anti-obesity benefit. Where the benefit is included, prior authorization is required: BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), plus documented lifestyle program participation and weight-loss maintenance for renewal. If the employer did not opt in, weight-loss Wegovy is excluded — this is a benefit design decision, not a medical-necessity denial. ACA/individual-market plans generally exclude Wegovy for weight loss. Wisconsin Medicaid GLP-1 obesity coverage is state-dependent; verify on the WI Medicaid PDL. Per-plan drug tier and cost-share are not publicly published at the drug level — verify via Security Health Plan's drug-lookup tool. Commercially insured members whose plan covers Wegovy may use the NovoCare savings card at $25/month (max $100 per 28-day supply; not available to Medicare or Medicaid).

Prior authorization

The 4 boxes you must tick to get approved

Commercial plans that will consider Wegovy require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 4

Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Wegovy actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

$1,349/month (Novo Nordisk published list price for a 28-day supply). NovoCare self-pay: approximately $349/month for standard injection doses after an introductory period through December 31, 2026.

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Plan-specific cost-share where covered — not publicly published at the drug level. Confirm your specific cost-share on Security Health Plan's drug-lookup tool or member portal. NovoCare savings card: commercially insured members whose plan covers Wegovy may pay as little as $25/month (max $100 per 28-day supply). Not available to Medicare or Medicaid beneficiaries.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

Medicare GLP-1 Bridge: $50/month fixed copay for eligible Medicare beneficiaries, launching July 1, 2026, through December 31, 2027. Operates outside Part D — does not count toward the $2,100 OOP cap, TrOOP, or Extra Help. Provider must attest eligibility at initiation.

Reduced copay through the assistance program, where eligible.

All cost figures are estimates. Actual cost-share varies by plan tier, deductible phase, and pharmacy — confirm with your Security Health Plan and pharmacist before starting treatment.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Ask HR whether your employer included the anti-obesity benefit

    Being a Security Health Plan member affiliated with Marshfield Clinic does not automatically include anti-obesity drug coverage. Confirm with your HR benefits team whether weight-loss medications are in your employer plan. If excluded, no PA will succeed — it is a benefit design decision.

  2. 2

    Search Security Health Plan's drug-lookup tool for your specific plan

    Go to securityhealthplan.com and use the formulary or drug-lookup tool with your member ID. Search for 'Wegovy' or 'semaglutide 2.4 mg' to confirm tier, PA requirements, and quantity limits for your actual plan.

  3. 3

    Work with your Marshfield Clinic or other prescriber on prior authorization

    If your plan covers Wegovy, your prescriber (whether a Marshfield Clinic provider or otherwise) will submit a PA to Security Health Plan. Gather documentation: BMI measurement, relevant comorbidities, and evidence of lifestyle program participation. Track weight-loss progress before each renewal to meet the reauthorization threshold.

If it's denied

Options if Security Health Plan won't cover Wegovy

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Ozempic (semaglutide for T2D)

If you have type 2 diabetes, Ozempic (semaglutide) is broadly covered for T2D with PA across most commercial plans regardless of the anti-obesity benefit. Ozempic is not FDA-approved for weight loss and should not be prescribed for that indication.

NovoCare self-pay program

Novo Nordisk's NovoCare Pharmacy offers Wegovy at approximately $349/month for patients without coverage. An introductory rate of approximately $199/month applies to the 0.25 and 0.5 mg doses through December 31, 2026. List price is announced to drop to approximately $675/month effective January 1, 2027.

Compounded semaglutide

Compounded semaglutide is available without insurance for patients who cannot access covered Wegovy. See the Curex offer below. Compounded medications are not the same as Wegovy and have not been approved by the FDA.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

Security Health Plan covers Wegovy for weight loss only on employer plans where the anti-obesity benefit was purchased. Drug-level Wegovy detail is not publicly published — verify on the drug-lookup tool at securityhealthplan.com or by calling member services. ACA/individual plans generally exclude weight-loss GLP-1s. Being part of the Marshfield Clinic integrated system does not automatically include anti-obesity drug coverage; that is determined by your specific employer's benefit design.

Both Security Health Plan and Network Health are Wisconsin regional plans with not-publicly-published Wegovy detail gating weight-loss coverage on employer opt-in. The distinguishing feature is delivery model: Security Health Plan is affiliated with Marshfield Clinic, an integrated health system, while Network Health is an independent commercial insurer with a notable Medicare Advantage book. For commercial weight-loss seekers, the coverage logic is the same — employer benefit design decides — but Security Health Plan members with complex chronic conditions may benefit from Marshfield's integrated prescribing relationship when navigating the PA process.

Where the anti-obesity benefit is included, Security Health Plan requires PA with BMI 30 or higher (or 27 with a weight-related comorbidity such as hypertension, T2D, dyslipidemia, or sleep apnea), documented lifestyle program participation, and demonstrated weight-loss progress for renewal. Specific Security Health Plan PA criteria are not publicly published — confirm current requirements with member services or your prescriber before submitting.

No. Medicare Part D cannot cover Wegovy for weight loss by statute — this is a federal rule applying to all plans including Security Health Plan Medicare plans. Security Health Plan Medicare plans can cover Wegovy for the cardiovascular risk-reduction indication in members with established CVD. The Medicare GLP-1 Bridge (launching July 1, 2026) provides weight-loss access at $50/month outside Part D for eligible beneficiaries — verify Bridge eligibility criteria with your prescriber.

Being cared for at Marshfield Clinic can streamline the prior authorization process because your prescriber has integrated access to your health records, making it easier to document BMI, comorbidities, and lifestyle program participation. However, the coverage decision itself — whether your employer plan includes the anti-obesity benefit — is entirely independent of the Marshfield delivery system. An integrated prescriber cannot override a benefit design exclusion. What the integrated system helps with is the paperwork once you confirm the benefit exists.

The Curex GLP-1 program

Whether or not Security Health Plan covers Wegovy, there's a path that skips insurance

Security Health Plan covers Wegovy for weight loss only where the employer opted in. For patients without that benefit, Curex offers compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) at getcurex.com/cl/glp — no insurance, no prior authorization. Compounded semaglutide is not the same medication as Wegovy. Prescription required, subject to provider review.

Compounded semaglutide
from$49/mo
Weekly injection or oral tablet
Compounded tirzepatide
from$149/mo
Injection or oral tablet
  • Medication + free shipping
  • 24/7 provider access
  • Medical intake & prescription review
From $49/moNo insurance requiredNo prior auth
Build your personalized planPrescription required, subject to provider review.

Compounded semaglutide and tirzepatide are not the same medications as Wegovy and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Security Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Wegovy and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

Weight care with Curex

Whether or not Security Health Plan covers Wegovy, there's a path that skips insurance

Build your personalized plan

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.